Prostate cancer: Treatment triggers for patients on active surveillance

William M. Hilton, Dipen J Parekh

Research output: Contribution to journalArticle

Abstract

Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

Original languageEnglish
Pages (from-to)126-127
Number of pages2
JournalNature Reviews Urology
Volume8
Issue number3
DOIs
StatePublished - Apr 1 2011
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Biopsy
Neoplasm Grading
Therapeutics
Medical Overuse

ASJC Scopus subject areas

  • Urology

Cite this

Prostate cancer : Treatment triggers for patients on active surveillance. / Hilton, William M.; Parekh, Dipen J.

In: Nature Reviews Urology, Vol. 8, No. 3, 01.04.2011, p. 126-127.

Research output: Contribution to journalArticle

@article{d43ec376382343568020104a76fb052c,
title = "Prostate cancer: Treatment triggers for patients on active surveillance",
abstract = "Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.",
author = "Hilton, {William M.} and Parekh, {Dipen J}",
year = "2011",
month = "4",
day = "1",
doi = "10.1038/nrurol.2010.235",
language = "English",
volume = "8",
pages = "126--127",
journal = "Nature Reviews Urology",
issn = "1759-4812",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Prostate cancer

T2 - Treatment triggers for patients on active surveillance

AU - Hilton, William M.

AU - Parekh, Dipen J

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

AB - Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

UR - http://www.scopus.com/inward/record.url?scp=79952708560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952708560&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2010.235

DO - 10.1038/nrurol.2010.235

M3 - Article

C2 - 21243020

AN - SCOPUS:79952708560

VL - 8

SP - 126

EP - 127

JO - Nature Reviews Urology

JF - Nature Reviews Urology

SN - 1759-4812

IS - 3

ER -